IPO Listed — 25 Jun 2026
Listing Price: ₹395.20 (+90% vs ₹208)
Avience Biomedicals SME IPO Review
Avience Biomedicals SME IPO is yet to receive analyst coverage — analyst reports and verdicts will be updated here as and when they are published. The IPO is priced in the band of ₹196-208 per share with a minimum lot size of 600 shares (minimum investment of ₹124,800) . Subscription ran from 18 Jun 2026 to 22 Jun 2026. In the meantime, you can track the live GMP and subscription status for early market signals.
Table of Contents
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Avience Biomedicals SME IPO?
Analyst coverage for Avience Biomedicals SME IPO has not been published yet. Analyst verdicts will be updated here as they come in — check back closer to the subscription dates.
What does the score of N/A mean for Avience Biomedicals SME IPO?
Analyst scoring is not yet available for Avience Biomedicals SME IPO. The score will be updated once analyst reports start coming in.
What was the actual listing price of Avience Biomedicals SME IPO?
Avience Biomedicals SME IPO listed on June 25, 2026 at ₹395.20 , against the issue price of ₹208 — a gain of +90% (₹187.2 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Avience Biomedicals SME IPO?
Avience Biomedicals SME IPO was priced at ₹196-208 per share. The minimum lot size is 600 shares, making the minimum investment approximately ₹124,800 at the upper end of the price band. Subscription ran from 18 Jun 2026 to 22 Jun 2026.
Explore Avience Biomedicals SME IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!